[{"_id":"55200a43b6241657bb271182","会社名":"日本新薬(株)【4516】","証券コード":"4516","決算期":"2014年3月期","会計方式":"日本方式","決算発表日":"2014年5月9日","決算月数":"12か月","売上高":"76,517百万円","営業利益":"8,038百万円","経常利益":"8,598百万円","当期利益":"5,750百万円","EPS（一株当たり利益）":"85.25円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,378.93円","総資産":"118,188百万円","自己資本":"92,982百万円","資本金":"5,174百万円","有利子負債":"---","自己資本比率":"78.7%","ROA（総資産利益率）":"4.96%","ROE（自己資本利益率）":"6.31%","総資産経常利益率":"7.41%","__v":0,"日付":"2015-04-04T15:58:59.118Z"},{"_id":"55200a43b6241657bb271183","会社名":"日本新薬(株)【4516】","証券コード":"4516","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月13日","決算月数":"12か月","売上高":"69,941百万円","営業利益":"6,901百万円","経常利益":"7,209百万円","当期利益":"4,647百万円","EPS（一株当たり利益）":"68.87円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,323.87円","総資産":"113,730百万円","自己資本":"89,331百万円","資本金":"5,174百万円","有利子負債":"---","自己資本比率":"78.5%","ROA（総資産利益率）":"4.22%","ROE（自己資本利益率）":"5.35%","総資産経常利益率":"6.55%","__v":0,"日付":"2015-04-04T15:58:59.119Z"},{"_id":"55200a43b6241657bb271184","会社名":"日本新薬(株)【4516】","証券コード":"4516","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年5月10日","決算月数":"12か月","売上高":"67,304百万円","営業利益":"6,012百万円","経常利益":"6,193百万円","当期利益":"3,715百万円","EPS（一株当たり利益）":"55.04円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,250.11円","総資産":"106,304百万円","自己資本":"84,375百万円","資本金":"5,174百万円","有利子負債":"---","自己資本比率":"79.4%","ROA（総資産利益率）":"3.55%","ROE（自己資本利益率）":"4.48%","総資産経常利益率":"5.93%","__v":0,"日付":"2015-04-04T15:58:59.119Z"}]